The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Value Is Anticipated For The Single Cell Multiomics Market Over The Period 2026–2030?
The size of the single cell multiomics market has experienced rapid expansion over recent years. This market is projected to expand from $4.85 billion in 2025 to $5.92 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 22.1%. The historical growth of this market can be linked to several factors, including improvements in single-cell sequencing technologies, an increase in cancer research efforts, greater investment in life sciences research, enhanced access to high-throughput analysis instruments, and increased financial support for academic research.
The single cell multiomics market size is projected for rapid expansion over the next few years. It is anticipated to reach $13 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 21.7%. This growth during the forecast period is primarily driven by rising demand for precision medicine applications, increasing adoption in clinical research workflows, the expansion of multiomics data integration platforms, growing investments in pharmaceutical research, and continuous improvements in analytical sensitivity. Key trends in the forecast period encompass the increasing adoption of integrated multiomics platforms, a rising demand for high-resolution single-cell analysis, the growing use of AI-driven data interpretation tools, the expansion of multi-modal cellular profiling techniques, and an enhanced focus on insights into cellular heterogeneity.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20630&type=smp
Which Economic Or Industry Drivers Are Impacting The Single Cell Multiomics Market?
The escalating demand for precision medicine is projected to stimulate the growth of the single cell multiomics market moving forward. Precision medicine refers to a medical methodology that customizes treatment and healthcare approaches based on the unique characteristics of individual patients. This increase in precision medicine is spurred by advancements in genomic research, enhanced data analysis capabilities, and a clearer understanding of the advantages of personalized healthcare. Single-cell multiomics delivers detailed insights into cellular heterogeneity and molecular mechanisms, enabling the formulation of highly personalized treatments tailored to the distinct cellular profiles of individual patients. For instance, in May 2025, the U.S. Food and Drug Administration (FDA) approved 18 new personalized medicines in 2023, representing about 38% of all newly approved therapeutic molecular entities, according to the U.S.-based professional organization, the Personalized Medicine Coalition (PMC). Therefore, the escalating demand for precision medicine is driving the expansion of the single cell multiomics market.
How Is The Single Cell Multiomics Market Divided Into Its Major Segments?
The single cell multiomics market covered in this report is segmented –
1) By Type: Single Cell Genomics, Single Cell Proteomics, Single Cell Transcriptomics, Single Cell Metabolomics
2) By Technique: Single Cell Isolation And Dispensing, Single Cell Analysis
3) By Application: Oncology, Cell Biology, Neurology, Immunology, Stem Cell Research
4) By End User: Academic Institutes, Contract Research Organizations, Pharmaceutical And Biotech Companies
Subsegments:
1) By Single Cell Genomics: Whole Genome Sequencing (WGS), Targeted Sequencing, Single Cell DNA Amplification Techniques, Genomic Analysis Platforms
2) By Single Cell Proteomics: Mass Spectrometry-Based Techniques, Protein Microarrays, Enzyme-Linked Immunosorbent Assays (ELISA), Single Cell Protein Analysis Platforms
3) By Single Cell Transcriptomics: Single Cell RNA Sequencing (scRNA-seq), RNA Amplification Techniques, Microfluidics-Based Transcriptomics, Transcriptome Analysis Tools
4) By Single Cell Metabolomics: Mass Spectrometry For Metabolite Analysis, Nuclear Magnetic Resonance (NMR) Techniques, Liquid Chromatography For Metabolomics, Metabolite Profiling Tools
What Trends Are Advancing Progress In The Single Cell Multiomics Market?
Leading companies in the single cell multiomics market are actively developing single-cell multiomics tests to improve the accuracy and resolution of cellular analysis. These tests empower researchers to gain a deeper understanding of complex biological processes, identify scarce cell populations, and customize precision medicine strategies by consolidating extensive molecular data from individual cells. For example, in June 2024, Mission Bio, a US-based biotechnology company, introduced its Tapestri Single-cell Multiple Myeloma Multiomics Solution. This solution facilitates thorough profiling of multiple myeloma at a single-cell level, allowing translational researchers and drug developers to meticulously examine the molecular and cellular landscape during myeloid progression, comprehend therapy resistance, and pinpoint the catalysts of disease evolution from early stages like monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM).
Who Are The Prominent Organizations Shaping The Single Cell Multiomics Market?
Major companies operating in the single cell multiomics market are Thermo Fisher Scientific Inc., Danaher Corporation, Becton Dickinson and Company, Illumina Inc., BioRad Laboratories Inc., QIAGEN N.V., BioTechne Corporation, Miltenyi Biotec BV & Co KG, BGI Genomics Co Ltd, 10x Genomics Inc., Molecular Devices LLC, NanoString Technologies Inc., Standard BioTools Inc., Akoya Biosciences Inc., Takara Bio Inc., Synthego Corporation, Mission Bio Inc., DeepCell Inc., RareCyte Inc., Parse Biosciences Inc., Dolomite Bio Ltd, Stilla Technologies SAS, NanoCellect Biomedical Inc., Epicypher Inc., Scipio Biosciences SAS
Read the full single cell multiomics market report here:
https://www.thebusinessresearchcompany.com/report/single-cell-multiomics-global-market-report
What Are The Top-Performing Regions Within The Single Cell Multiomics Market?
North America was the largest region in the single cell multiomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single cell multiomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Single Cell Multiomics Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=20630&type=smp
Browse Through More Reports Similar to the Global Single Cell Multiomics Market 2026, By The Business Research Company
Flow Cytometry In Oncology And Immunology Global Market Report
Stem Cell Global Market Report
https://www.thebusinessresearchcompany.com/report/stem-cell-global-market-report
Cellular Telephone Global Market Report
https://www.thebusinessresearchcompany.com/report/cellular-telephone-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model